Company Filing History:
Years Active: 2017-2024
Title: The Innovative Journey of Sandra Werner
Introduction
Sandra Werner is an accomplished inventor based in Ostwald, France, known for her significant contributions to the field of pharmaceuticals. With a total of seven patents to her name, Sandra has been a pivotal figure in the development of controlled release dosage forms that have been beneficial in treating various disorders, particularly in the realm of neurology.
Latest Patents
One of Sandra's notable patents is for gastro-resistant controlled release oral dosage forms. This innovative formulation comprises Compound (I) or a pharmaceutically acceptable salt and/or solvate. The pharmacokinetic properties of these dosage forms are specifically designed to reduce the risk of QT prolongation in subjects, which is especially valuable for patients diagnosed with schizophrenia, aiding in the treatment of negative symptoms associated with the condition.
Another significant patent is for the L-lysine salt of 4-chloro-5-[4-(2,6-dichlorophenyl)sulfonylpiperazin-1-yl]-1-benzofuran-2-carboxylic acid and its various forms. This invention extends to pharmaceutical and veterinary compositions involving this salt, offering therapeutic benefits for a range of diseases.
Career Highlights
Throughout her career, Sandra has worked with prominent companies such as Minerva Neurosciences, Inc. and Enyo Pharma. Her work has been instrumental in advancing pharmaceutical science, particularly in the development of novel drug delivery systems that enhance therapeutic efficacy.
Collaborations
Sandra has collaborated with several talented individuals in her journey, including Remy Henri Luthringer and Nadine Noel. These collaborations have further enriched her work, allowing for the exchange of ideas and expertise in the field of pharmaceutical innovation.
Conclusion
Sandra Werner's innovative spirit and dedication to improving healthcare through her inventions exemplify the role of inventors in transforming scientific research into real-world applications. With her extensive portfolio of patents and impactful collaborations, she continues to pave the way for future advancements in the pharmaceutical industry.